126 related articles for article (PubMed ID: 14661689)
1. Imatinib mesylate-induced interstitial pneumonitis.
Ma CX; Hobday TJ; Jett JR
Mayo Clin Proc; 2003 Dec; 78(12):1578-9. PubMed ID: 14661689
[No Abstract] [Full Text] [Related]
2. Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms.
Grimison P; Goldstein D; Schneeweiss J; Murray N
Intern Med J; 2005 Feb; 35(2):136-7. PubMed ID: 15705148
[No Abstract] [Full Text] [Related]
3. [A rare complication of imatinib mesylate therapy: drug-induced pneumonitis].
Stakhina OV; Turkina AG; Kostina IE; Kochkareva IuB
Ter Arkh; 2010; 82(2):59-61. PubMed ID: 20387680
[TBL] [Abstract][Full Text] [Related]
4. Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltration.
Yokoyama T; Miyazawa K; Kurakawa E; Nagate A; Shimamoto T; Iwaya K; Akata S; Aoshima M; Serizawa H; Ohyashiki K
Leukemia; 2004 Mar; 18(3):645-6. PubMed ID: 14724651
[No Abstract] [Full Text] [Related]
5. Reversible drug-induced interstitial pneumonitis following imatinib mesylate therapy.
Rajda J; Phatak PD
Am J Hematol; 2005 May; 79(1):80-1. PubMed ID: 15849772
[No Abstract] [Full Text] [Related]
6. Interstitial pneumonitis during imatinib therapy.
Isshiki I; Yamaguchi K; Okamoto S
Br J Haematol; 2004 May; 125(4):420. PubMed ID: 15142112
[No Abstract] [Full Text] [Related]
7. Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis.
Rosado MF; Donna E; Ahn YS
J Clin Oncol; 2003 Aug; 21(16):3171-3. PubMed ID: 12915610
[No Abstract] [Full Text] [Related]
8. Irreversible imatinib-induced pneumonitis following long-term imatinib administration.
Seki N; Ito A; Watanabe K; Shibakuki R; Seto T; Uematsu K; Mine T; Eguchi K
Intern Med; 2007; 46(23):1941-2. PubMed ID: 18057772
[No Abstract] [Full Text] [Related]
9. Lack of recurrence of imatinib-induced interstitial lung disease with nilotinib.
Delomas T; Darné C; Besson C
Leuk Lymphoma; 2012 Feb; 53(2):332-3. PubMed ID: 21823828
[No Abstract] [Full Text] [Related]
10. Drug-induced pneumonitis associated with imatinib mesylate in a patient with idiopathic pulmonary fibrosis.
Yamasawa H; Sugiyama Y; Bando M; Ohno S
Respiration; 2008; 75(3):350-4. PubMed ID: 16449804
[TBL] [Abstract][Full Text] [Related]
11. Imatinib-induced interstitial lung disease and sunitinib-associated intra-tumour haemorrhage.
Loong HH; Yeo W
Hong Kong Med J; 2008 Dec; 14(6):495-8. PubMed ID: 19060352
[TBL] [Abstract][Full Text] [Related]
12. Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate.
Ohnishi K; Sakai F; Kudoh S; Ohno R
Leukemia; 2006 Jun; 20(6):1162-4. PubMed ID: 16598305
[No Abstract] [Full Text] [Related]
13. Fulminant, but reversible interstitial pneumonitis associated with imatinib mesylate.
Lin JT; Yeh KT; Fang HY; Chang CS
Leuk Lymphoma; 2006 Aug; 47(8):1693-5. PubMed ID: 16966290
[No Abstract] [Full Text] [Related]
14. Pulmonary toxicities of tyrosine kinase inhibitors.
Peerzada MM; Spiro TP; Daw HA
Clin Adv Hematol Oncol; 2011 Nov; 9(11):824-36. PubMed ID: 22252615
[TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate induced skin hypopigmentation.
Talwar V; Doval DC; Bhatia K
J Assoc Physicians India; 2007 Jul; 55():527. PubMed ID: 17907508
[No Abstract] [Full Text] [Related]
16. Erythema following imatinib mesylate.
Duncan E; Raj K; Mufti G
Br J Haematol; 2003 Jul; 122(1):1. PubMed ID: 12823338
[No Abstract] [Full Text] [Related]
17. An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient.
Aliberti S; Grignani G; Allione P; Fizzotti M; Galatola G; Pisacane A; Aglietta M
Am J Clin Oncol; 2009 Dec; 32(6):640-1. PubMed ID: 19955903
[No Abstract] [Full Text] [Related]
18. [Imatinib-induced pulmonary toxicity].
Carrillo-Esper R; Morales-Victorino N
Gac Med Mex; 2009; 145(5):437-9. PubMed ID: 20073450
[TBL] [Abstract][Full Text] [Related]
19. Another look at imatinib mesylate.
Strebhardt K; Ullrich A
N Engl J Med; 2006 Dec; 355(23):2481-2. PubMed ID: 17151370
[No Abstract] [Full Text] [Related]
20. Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib.
Ikezoe T; Togitani K; Tasaka T; Nishioka C; Yokoyama A
Leuk Res; 2010 Aug; 34(8):e200-1. PubMed ID: 20303172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
